Current status of Hemobahn/Viabahn endografts for treatment of popliteal aneurysms.

Current status of Hemobahn/Viabahn endografts for treatment of popliteal aneurysms. J Cardiovasc Surg (Torino). 2013 Dec;54(6):785-791 Authors: Möllenhoff C, Katsargyris A, Steinbauer M, Tielliu I, Verhoeven EL Abstract The aim of the present study was to review the literature reporting the use of the Hemobahn/Viabahn endograft (W. L. Gore and Assoc Inc., Flagstaff, AZ, USA) for endovascular treatment of popliteal artery aneurysms (PAA). A PubMed database search was performed looking for studies reporting endovascular treatment of PAA with the Hemobahn/Viabahn endograft within the period January 2000-December 2012. All relevant studies were independently assessed and all references were examined for potentially missed relevant reports. Studies were included if they reported experience with five patients or more. Eight studies with 222 patients (mean age 72.4 years, 92.3% male) and 251 PAA (mean diameter 2.9 mm, 14.3% symptomatic) were included. Thirteen cases (5.2%) were treated on an urgent basis, including three cases of ruptured PAA and 10 cases of acute limb ischemia. Initial technical success was 99.2%. The mean number of implanted endografts/PAA was 1.8 (range 1-4). Thirty-day mortality was 1 (0.4%) patient. Perioperative complications occurred in 1.6%, consisting of three access site hematomas and one acute endograft thrombosis. Cumulative mean follow-up duration was 36.9 months. During this period, a total of 46 endograft failures (42...
Source: The Journal of Cardiovascular Surgery - Category: Cardiovascular & Thoracic Surgery Authors: Tags: J Cardiovasc Surg (Torino) Source Type: research